Literature DB >> 11805439

Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patients.

C Briones1, A Mas, M Pérez-Olmeda, C Altisent, E Domingo, V Soriano.   

Abstract

The emergence of resistance to antiretroviral drugs represents one of the main reasons for treatment failure in HIV-infected persons. Resistance to multiple nucleoside analogues may result from rearrangements in the HIV pol gene, in particular one insertion of two amino acids at position 69. Herein, we examined the prevalence of this resistant genotype and its genetic heterogeneity in a group of 475 healthy pretreated HIV-positive subjects in Spain. Only 4 (0.8%) carried the codon 69 insertion. It was always found coupled to the T69S mutation. The extra amino acids were S-S in 2 subjects and S-G in the other 2. The presence of the insert was seen only in subjects previously exposed to AZT monotherapy for at least 6 months. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11805439     DOI: 10.1159/000050068

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  2 in total

1.  Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.

Authors:  Lia van der Hoek; Nicole Back; Maarten F Jebbink; Anthony de Ronde; Margreet Bakker; Suzanne Jurriaans; Peter Reiss; Neil Parkin; Ben Berkhout
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

2.  Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation.

Authors:  Peter R Meyer; Johan Lennerstrand; Suzanne E Matsuura; Brendan A Larder; Walter A Scott
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.